(19)
(11) EP 1 206 449 A1

(12)

(43) Date of publication:
22.05.2002 Bulletin 2002/21

(21) Application number: 00950642.9

(22) Date of filing: 26.07.2000
(51) International Patent Classification (IPC)7C07D 207/26, C07D 211/76, C07D 223/10, C07D 233/12, C07F 5/02, A61K 31/4015, A61K 31/45, A61K 31/55, A61K 33/22, A61P 31/14
(86) International application number:
PCT/US0020/189
(87) International publication number:
WO 0107/407 (01.02.2001 Gazette 2001/05)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.07.1999 US 145631 P

(71) Applicant: BRISTOL-MYERS SQUIBB COMPANY
Princeton, NJ 08543-4000 (US)

(72) Inventors:
  • PRIESTLEY, E., Scott
    Hockessin, DE 19707 (US)
  • DECICCO, Carl, P.
    Kennett Square, PA 19348 (US)

(74) Representative: Howard, Paul Nicholas et al
Carpmaels & Ransford43 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) LACTAM INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE